Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05089771 in painful diabetic peripheral neuropathy
NCT02215252Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-05089771 in diabetic peripheral neuropathy (DPN), sponsored by Pfizer. Started Nov 2014; status: completed.
02
Drugs
PF-05089771
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT02215252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215252.